Citadel Advisors - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 44 filers reported holding AYTU BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q3 2022$17,000
-83.3%
92,100
-37.6%
0.00%
Q2 2022$102,000
+4.1%
147,500
+63.2%
0.00%
Q1 2022$98,000
-65.2%
90,400
-56.8%
0.00%
Q4 2021$282,000
-30.4%
209,427
+49.0%
0.00%
Q3 2021$405,000
-9.6%
140,549
+57.1%
0.00%
Q2 2021$448,000
+138.3%
89,479
+261.4%
0.00%
Q1 2021$188,000
-62.4%
24,761
-70.4%
0.00%
Q4 2020$500,00083,6760.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,398,776$8,365,0006.40%
ARMISTICE CAPITAL, LLC 1,333,334$7,973,0000.27%
PIPER SANDLER & CO. 49,590$297,0000.21%
SEARLE & CO. 14,000$84,0000.04%
WINTON GROUP Ltd 28,653$171,0000.01%
Squarepoint Ops LLC 34,862$208,0000.00%
BELLEVUE ASSET MANAGEMENT, LLC 260$2,0000.00%
Clearstead Advisors, LLC 1,421$8,0000.00%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 889$5,0000.00%
Ameritas Investment Partners, Inc. 202$1,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders